UF Researcher Yongpei Guan, Ph.D., Named 2021 IEEE Fellow
Yongpei Guan, Ph.D., a professor in the Department of Industrial & Systems Engineering (ISE) at the University of Florida, has been elevated to Fellow status in The Institute of Electrical and Electronics Engineers (IEEE).
University of Florida Focusing on AI
Researchers with the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) are working as teams to use artificial intelligence (AI) to attack complex issues.
Oxidien Pharmaceuticals Announce Additions to New Strategic Advisory Board
UF Innovate | The Hub resident client Oxidien Pharmaceuticals announced two additions to its newly organized Strategic Advisory Board (SAB).
AbFero Pharmaceuticals Announces Funding From Cure Parkinson’s for Lead Compound SP-420
AbFero Ltd., a subsidiary of UF startup AbFero Pharmaceuticals, Inc., a privately-held clinical stage pharmaceutical company dedicated to treating diseases of iron overload, announced the award of a grant from Cure Parkinson's for the development of their lead, brain-penetrant iron chelating agent, SP-420, as a disease modifying therapy for Parkinson's disease (PD).
UF Health Jacksonville Is First Site To Test Drug To Prevent Excessive Bleeding
UF Health Jacksonville is the first site in the world to test a new drug designed to prevent excessive bleeding that can occur from taking ticagrelor, a popular blood-thinning medication sold under the brand name Brilinta.
UF Health Virtual Human Intervention Allows for Colorectal Cancer Screening From Home
A new University of Florida Health intervention gives patients who qualify access to colorectal cancer screening information and tests from the comfort of their own homes.
Unsure About the COVID-19 Vaccine? UF Health’s Chief Epidemiologist Has Answers
Nicole M. Iovine, M.D., Ph.D., chief epidemiology officer for the University of Florida Health Shands Hospital system, addresses key issues related to overcoming vaccine hesitancy.
DNAtrix Announces Preclinical Data Demonstrating Anti-Tumor Activity of DNX-2401 in Models of Pediatric Tumors Published in Clinical Cancer Research
UF startup DNAtrix, a biotech company advancing virus-driven immunotherapies for cancer, announced preclinical data evaluating the use of DNX-2401 against the pediatric brain malignancies atypical teratoid/rhabdoid tumor (AT/RT) and primitive neuroectodermal tumors (PNETs) was published in Clinical Cancer Research.
Economic Impact
Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.
UF Researcher Will Lead CureSearch for Children’s Cancer $1 Million Gift To Support Cutting-Edge Immunotherapy Trial for Pediatric High-Grade Glioma
CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing innovative personalized immunotherapy for pediatric high-grade gliomas, the primary cause of death in children with brain tumors. The project is funded through a CureSearch Catapult Award granted to pediatric oncologist Elias Sayour, MD, Ph.D. at the University of Florida.
